Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 1 Apr 2011

Long Georgina V, Menzies Alexander M, Nagrial Adnan M, Haydu Lauren E, Hamilton Anne L, Mann Graham J, Hughes T Michael, Thompson John F, Scolyer Richard A, Kefford Richard F

Abstract excerpt

PURPOSE: To assess the frequency and type of oncogenic BRAF mutations in metastatic melanoma and correlate BRAF status with clinicopathologic features and outcome. PATIENTS AND METHODS: Consecutive BRAF-tested Australian patients with metastatic melanoma (n = 197) were observed prospectively. A c...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clinical Trials, Phase I as Topic
Share to Clinical Trials, Phase II as Topic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease-Free Survival

Share to Kaplan-Meier Estimate

Share to Melanoma

Share to New South Wales

Share to Proportional Hazards Models

Share to Skin Neoplasms

Source

Identifiers

PMID: 21343559
DOI: 10.1200/JCO.2010.32.4327

Genes

BRAF

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-21343559-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma.PMID 21343559Read ↗

Distinguishing clinicopathologic features of patients with V600E and V600K BRAF-mutant metastatic melanoma.Semantic proximity Read ↗

The clinical significance of BRAF and NRAS mutations in a clinic-based metastatic melanoma cohort.Semantic proximity Read ↗

The role of BRAF mutations in primary melanoma growth rate and survival.Semantic proximity Read ↗

Biology and Treatment of BRAF Mutant Metastatic MelanomaSemantic proximity Read ↗

Clinical significance of BRAF mutations in metastatic melanomaSemantic proximity Read ↗

Correlation of BRAF and NRAS mutation status with outcome, site of distant metastasis and response to chemotherapy in metastatic melanoma.Semantic proximity Read ↗

The molecular profile of metastatic melanoma in Australia.Semantic proximity Read ↗

Incidence of BRAF oncogene mutation and clinical relevance for primary cutaneous melanomas.Semantic proximity Read ↗

Clinical characteristics and outcomes with specific BRAF and NRAS mutations in patients with metastatic melanoma.Semantic proximity Read ↗

Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.Semantic proximity Read ↗

Is BRAF a prognostic factor in stage III skin melanoma? A retrospective study of 72 patients after positive sentinel lymph node dissection.Semantic proximity Read ↗

Metastatic melanoma of unknown primary resembles the genotype of cutaneous melanomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.